Jann M W, Ereshefsky L, Saklad S R, Seidel D R, Davis C M, Burch N R, Bowden C L
J Clin Psychopharmacol. 1985 Apr;5(2):106-9. doi: 10.1097/00004714-198504000-00010.
Plasma haloperidol levels were monitored in three schizophrenic patients when carbamazepine was either added or discontinued. The percent decrease in plasma haloperidol levels due to concomitant carbamazepine therapy was between 59% and 61%. The effects of carbamazepine on plasma haloperidol levels were noted to occur in 2 to 3 weeks. Although no adverse effects occurred in the patients during therapy, careful monitoring of clinical symptoms and plasma haloperidol levels is recommended.
在三名精神分裂症患者中,当添加或停用卡马西平时监测了血浆氟哌啶醇水平。由于联合使用卡马西平治疗导致血浆氟哌啶醇水平下降的百分比在59%至61%之间。注意到卡马西平对血浆氟哌啶醇水平的影响在2至3周内出现。尽管在治疗期间患者未出现不良反应,但建议仔细监测临床症状和血浆氟哌啶醇水平。